Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Gentamicin for UTI Prevention in Neurogenic Bladder
NCT03503513Phase 3Completed
- Sponsor
- University of Michigan
- Start
- Aug 2018
- Primary completion
- Sep 2023
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of gentamicin in urinary tract infection (UTI), sponsored by University of Michigan. Started Aug 2018; status: completed.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03503513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03503513.